Saving Seafood

Advocacy groups want FDA, not USDA, to regulate genetically engineered animals

April 12, 2021 — A wide-ranging collection of advocacy groups have sent letters to the U.S. Health and Human Services Department and U.S. Department of Agriculture, urging the leadersof the federal agencies to maintain regulatory authority over genetically engineered food animals within the U.S. Food and Drug Administration.

The push for FDA control is in response to a Trump administration proposal that sought to withdraw most of the FDA’s regulatory authority over genetically engineered animals, including fish, and transfer that authority to USDA’s Animal and Plant Health Inspection Service.

Read the full story at Seafood Source

FDA not meeting goals, following procedure on seafood warning letters, according to GAO report

March 19, 2021 — A report by the U.S. Government Accountability Office (GAO) released on 19 March found that the U.S. Food and Drug Administration (FDA) has been failing to follow its own procedures or meet key goals regarding warning letters sent to seafood companies violating food safety regulations.

The report, which came with a GAO recommendation that the FDA monitor whether it is following procedures and meeting goals for its warning letters, found that out of 125 warning letters sent for significant inspection violations, just 14 were properly followed up on. The FDA’s own goal for all warning letters requires follow-up inspections within six months to ensure violations have been corrected – a goal the administration rarely meets.

“For the letters that FDA sent from 2014 to early 2019, FDA didn’t consistently follow key procedures or meet key goals,” the GAO said in a press release.

The GAO analyzed 167 imported seafood warning letters issued by the FDA from 1 January, 2014, through 11 March, 2019, finding that for those letters the FDA “did not consistently follow key procedures or meet key goals for its warning letter process.”

Read the full story at Seafood Source

Oceana, NRDC call for expansion of Seafood Import Monitoring Program

March 8, 2021 — Marine sustainability non-governmental organization Oceana public on 3 March calling for the expansion of the U.S. Seafood Import Monitoring Program (SIMP) and for mandatory full-chain traceability requirements for all seafood sold in the United States.

The report, “Transparency and Traceability: Tools to Stop Illegal Fishing,” criticizes the current limitations of SIMP, in that the law currently applies to just 13 types of imported seafood and traces them to the U.S. border, not beyond. Extending SIMP to cover all seafood species sold in the United States, and requiring that all be covered by full-chain traceability from boat to plate, would reduce species mislabeling and help in the fight against illegal, unreported, and unregulated (IUU) fishing, Oceana said.

Read the full story at Seafood Source

Alliance for Meat, Poultry, Seafood Innovation & NFI Comment on Cell Cultured Labeling

March 8, 2021 — The following was released by the National Fisheries Institute:

Today, the Alliance for Meat, Poultry and Seafood Innovation (AMPS Innovation), an industry coalition representing the makers of cell-cultured meat, poultry and seafood products, and the National Fisheries Institute (NFI), a trade association that represents companies throughout the seafood production supply chain, jointly submitted comments to the U.S. Food and Drug Administration (FDA) in response to the agency’s Labeling of Foods Comprised of or Containing Cultured Seafood Cells Request for Information. The letter calls on the agency to support a framework that labels these new products descriptively, accurately, and consistently to represent what the products actually are, how they are made, and ensure robust consumer transparency.

Accordingly, the two groups believe that labeling of seafood products produced using cell-cultured technology should be thoughtfully based on the following key criteria:

  • Truthful, non-misleading, descriptive, and clear, communicating to the consumer what the product is and how it is produced, in line with FDA’s regulatory requirements,
  • Signal potential allergenicity and nutrition for consumer safety and transparency,
  • Non-disparaging to either cell-cultured or conventional seafood products, and
  • Differentiated from conventionally produced wild or farmed seafood products through a qualifier that modifies the conventional name of the product.

Based on peer-reviewed research carried out by Rutgers professor Dr. William Hallman, NFI and the super-majority of AMPS Innovation, including all of the cell-cultured seafood companies, urge the FDA to adopt and memorialize the sole use of the term “cell-cultured” to support uniform labeling within the seafood category.

Full text of the letter can be accessed here.

Under a joint framework for regulation of cell-cultured meat, poultry and seafood products, which was agreed to by the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) and the FDA in March 2019, the two agencies will work together to ensure the safety and labeling of cell-cultured meat, poultry, and seafood products.

Among other provisions of the framework, FSIS will have oversight of the labeling of cell-cultured meat and poultry, as it does for all meat and poultry sold in the United States, while FDA will oversee the labeling of cell-cultured seafood, as it does for most seafood sold in the United States. In a public presentation last summer, the agencies committed to joint principles for product labeling and labeling claims across cell-cultured meat, poultry and seafood products.

This is the second instance in which AMPS Innovation has partnered with an organization representing the conventional food and agriculture industry to align on labeling-related policies. In October 2020 AMPS Innovation and the North American Meat Institute (NAMI) sent a letter to FSIS calling for the agency to solicit input on what labeling for cell-cultured meat and poultry products should look like through an Advance Notice of Public Rulemaking.

About the Alliance for Meat, Poultry & Seafood Innovation
The Alliance for Meat, Poultry & Seafood Innovation is working to advance new methods of producing real, high-quality, safe meat, poultry and seafood products directly from cells, which, in partnership with the broader agricultural community, will help meet the demands of feeding a growing global population. AMPS Innovation advocates for our industry through sharing our collective expertise, providing insight into our innovation, and committing to safety and transparency with all stakeholders, including industry partners, policymakers, advocates and consumers. To learn more about the Alliance for Meat, Poultry & Seafood Innovation, visit www.ampsinnovation.org.

About the National Fisheries Institute
The National Fisheries Institute is a non-profit organization dedicated to education about seafood safety, sustainability, and nutrition. NFI and its members are committed to sustainable management of our oceans and being stewards of our environment by endorsing the United Nations Principles for Responsible Fisheries. Our investment in our oceans today will provide our children and future generations the health benefits of a plentiful supply of fish and seafood tomorrow. From responsible aquaculture, to a marketplace supporting free trade, to ensuring the media and consumers have the facts about the health benefits of fish and shellfish, NFI and its members support and promote sound public policy based on ground truth science. Learn more at www.aboutseafood.com.

US agencies find “no credible evidence” COVID-19 transmitted by food packaging

February 19, 2021 — In a rare joint statement, the United States Department of Agriculture (USDA), U.S. Food and Drug Administration (FDA), and U.S. Centers for Disease Control and Prevention (CDC) have firmly stated that there is “no credible evidence” that COVID-19 can be transmitted from food or food packaging.

The statement comes over a year into the COVID-19 pandemic, and months after very early studies indicated that COVID-19 might be able to travel on food. China has been one country that has taken the potential threat seriously, with customs slowdowns for heightened inspections of seafood and complete import closures from COVID-19 impacted countries. The country even falsely linked imported salmon to COVID-19 after an outbreak was linked to the Xinfadi market in Beijing, spooking seafood shoppers.

Read the full story at Seafood Source

USDA, FDA, CDC: “No Credible Evidence” Food Packaging Transmits COVID-19

February 18, 2021 — The following was released by the National Fisheries Institute:

Today the leadership of the U.S. Department of Agriculture (USDA), the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) all emphasized that food or food packing is not a likely source of COIVD-19 transmission. The rare joint statement said there is “no credible evidence” that the illness is transmitted that way.

“Today’s statement is an example of experts adhering to science and translating that high-level understanding into an important public health message,” said Lisa Weddig Vice President for Regulatory and Technical Affairs at the ‎National Fisheries Institute.

In today’s statement the USDA, FDA and CDC highlighted the safety of the U.S. food supply saying, “consumers should be reassured” that their confidence is based on “overwhelming international scientific consensus.”

“From epidemiologists to biologists, authorities are confident in the safety of the seafood supply and, what’s more, health experts cite seafood’s role in supporting a healthy immune system,” said Weddig.

The groups noted that a recent opinion from the International Commission on Microbiological Specifications for Foods said, “despite the billions of meals and food packages handled since the beginning of the COVID-19 pandemic, to date there has not been any evidence that food, food packaging or food handling is a source or important transmission route for [the disease.]”.

NFI encourages companies and countries to ensure their actions and policies are based on this scientific fact.

Seafood Processor Pleads Guilty to Selling Foreign Crabmeat Falsely Labeled as Blue Crab From USA

September 11, 2020 — The following was released by the U.S. Food and Drug Administration:

A North Carolina man pleaded guilty today before U.S. District Judge James C. Dever III in the Eastern District of North Carolina on charges that his company, Garland F. Fulcher Seafood Company Inc. (Garland Fulcher), at his direction, falsely labeled hundreds of thousands dollars’ worth of foreign crabmeat as “Product of USA.”

According to information in the public record, Jeffrey A. Styron was the treasurer of the corporate board of officers for Garland Fulcher, a North Carolina company engaged in the business of purchasing, processing, packaging, transporting and selling seafood and seafood products, including crabmeat from domestically harvested blue crab.

As treasurer, Styron was responsible for overseeing the daily operations of the company’s crab-related business, which involved managing and directing employees of the company with respect to the processing, packaging, and labeling of crab meat. Styron pleaded guilty to a one-count information charging him with substituting foreign crabmeat for domestic blue crab and, as part of the plea, Styron admitted to falsely labeling crabmeat with a retail market value of at least $250,000 dollars, which was sold primarily to small seafood retailers and restaurants.

“Blue crabs are a classic American seafood product and a vital resource for coastal communities in North Carolina, Virginia, Maryland, and other parts of the United States,” said Assistant Attorney General Jeffrey Bossert Clark for the Justice Department’s Environment and Natural Resources Division. “This investigation is part of the department’s mission to work with our law enforcement partners in the protection of Atlantic blue crab populations and other marine resources.”

“Seafood mislabeling is consumer fraud that undermines efforts of hardworking, honest fisherman and the free market by devaluing the price of domestic seafood,” said U.S. Attorney Robert J. Higdon Jr. for the Eastern District of North Carolina. “In this case, the fraudulent scheme artificially deflated the cost of domestic blue crab and gave Styron and Garland Fulcher Seafood an unacceptable and unfair economic advantage over law-abiding competitors.”

Read the full release here

FDA rejects historically low seafood imports in July

August 25, 2020 — The U.S. Food and Drug Administration (FDA) refused only 37 seafood entry lines in July, continuing a trend where federal officials were rejecting a historically low number of products.

According to the Southern Shrimp Alliance, that amount is by far a record low for the month. It’s only 21.3 percent of this historical average the alliance has tracked since 2002. It’s also significantly lower than the previous record low of 91 entry lines, which occurred last year.

Read the full story at Seafood Source

FDA Investigation of Scombrotoxin Fish Poisoning Linked to Yellowfin/Ahi Tuna/gassed tuna

November 20, 2019 — The following was released by the U.S. Food and Drug Administration:

FDA and state health authorities are investigating incidents of scombrotoxin fish poisoning linked to yellowfin tuna, also sometimes called ahi tuna. As a result of this investigation, FDA has placed Truong Phu Xanh Co, LTD of Vietnam on Import Alert, which provides information to FDA field staff that they may detain the firm’s yellowfin tuna without physical examination. Detained product will not enter the United States unless the importer proves that it meets U.S. food safety standards.

FDA asked for the supplier of yellowfin tuna associated with most of the illnesses, Truong Phu Xanh Co., LTD of Vietnam, to initiate a voluntary recall of all of its imported yellowfin tuna with production dates from January 2019 to the present. At this time, the firm has not recalled any product.

As part of the investigation, FDA evaluated the firm’s Hazard Analysis and Critical Control Point (HACCP) Plans. A HACCP Plan details a firm’s management system to address food safety through the analysis and control of biological, chemical, and physical hazards. Since FDA’s evaluation of this plan identified deficiencies, we asked for Truong Phu Xanh Co., LTD of Vietnam to initiate a voluntary recall of all of its imported yellowfin tuna with production dates from January 2019 to the present.
 
The investigation has identified 47 illnesses of scombrotoxin fish poisoning that occurred between August 8, 2019 and October 15, 2019.
 
Throughout the investigation, FDA and states have also been collecting product samples for testing. Scombrotoxin fish poisoning occurs when fish begin to spoil, resulting in increased histamine levels. Therefore, product samples cannot be linked to case patient samples through Whole Genome Sequencing (WGS) or Pulsed-Field Gel Electrophoresis (PFGE) analysis like for other foodborne illnesses, e.g., Salmonella or Listeria. Instead, samples are tested for decomposition and/or histamine levels. Multiple samples have been collected and analyzed, with positive results for decomposition or high histamine levels in products imported from Truong Phu Xanh Co., LTD.
 
FDA and state partners collected epidemiologic and traceback information for reported illnesses. As additional epidemiologic and traceback information was collected, FDA and state partners were able to work with companies throughout the supply chain to voluntarily recall implicated product. While recalls were conducted at various points in the supply chain, there may be additional product still on the market that could cause illness.
 
Ultimately, the coordinated investigation was able to identify Truong Phu Xanh Co., LTD as the common supplier of tuna that was likely consumed by most of the ill people.
 
Because scombrotoxin fish poisoning causes temporary or medically reversible adverse health consequences this incident did not meet the threshold for the use of FDA’s mandatory recall authority.
 
It has been determined that the source of the tuna for the illnesses announced by Seattle-King County Public Health Department is not related to Truong Phu Xanh Co., LTD.
 
Recommendations
 
Yellowfin tuna from Truong Phu Xanh Co., LTD with a production date in 2019 should not be consumed because it may have the potential to cause scombrotoxin fish poisoning. Tuna from this supplier could have been sold thawed or frozen; and could have been sold as ground tuna meat, poke cubes, steaks, or loins; this product could still be within its shelf life.­­
 
Scombrotoxin fish poisoning occurs when fish is not properly chilled or preserved and begins to spoil, resulting in increased histamine levels. Histamine cannot be destroyed by freezing or cooking.
 
Importers, Suppliers, and Distributors:
 
Importers, suppliers, and distributors should not use and should discard or destroy any yellowfin tuna imported from Truong Phu Xanh Co., LTD with a production date in 2019.
 
Restaurants and Retailers:
 
Restaurants and retailers should contact their suppliers to confirm the source of their yellowfin tuna because not all product was distributed in packaging that identifies Truong Phu Xanh Co., LTD. Yellowfin tuna imported from this company with a production date in 2019 should not be used, served, repacked, or sold; and should be discarded.
 
Consumers:
 
While we expect restaurants and retailers will have removed yellowfin tuna with a production date in 2019 from the Vietnamese supplier Truong Phu Xanh Co., LTD, consumers should ask if the yellowfin tuna being served or sold was imported from the Vietnamese supplier Truong Phu Xanh Co., LTD and has a production date in 2019.